Bench to Bedside: Platelet-rich Plasma—How Do We Adequately “Untranslate” Translational “Breakthroughs” in an After-market Setting?
Crossref DOI link: https://doi.org/10.1007/s11999-016-4992-z
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Potter, Benjamin K.
License valid from 2016-10-01